Click to search or browse MIMS
Icatibant is a selective competitive antagonist at the bradykinin type 2 (B2) receptor. It is a synthetic decapeptide with a structure similar to bradykinin, but with five non-proteinogenic amino acids.
In hereditary angioedema, increased bradykinin concentrations are the key mediator in the development of the clinical symptoms.
Further information: Jerini
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Read the latest issue online exclusively on MIMS Learning.
Access the full drug database and quick-reference tables on the go